D
DYADIC INTERNATIONAL INC
NASDAQ: DYAI (Dyadic International, Inc.)
最近更新时间: 1小时之前0.466
0.00 (0.22%)
| 前收盘价格 | 0.465 |
| 成交量 | 116,708 |
| 预期市盈率 (P/E Forward) | 15.82 |
| 价格/销量 (P/S) | 11.14 |
| 股市价格/股市净资产 (P/B) | 21.01 |
| 52周波幅 |
| 营业毛利率 | -163.94% |
| 营业利益率 (TTM) | -507.00% |
| 稀释每股收益 (EPS TTM) | -0.200 |
| 季度收入增长率 (YOY) | 17.60% |
| 总债务/股东权益 (D/E MRQ) | 548.39% |
| 流动比率 (MRQ) | 3.98 |
| 营业现金流 (OCF TTM) | -4.81 M |
| 杠杆自由现金流 (LFCF TTM) | -3.06 M |
| 资产报酬率 (ROA TTM) | -34.95% |
| 股东权益报酬率 (ROE TTM) | -214.26% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Dyadic International, Inc. | 混合的 | 看跌 |
AIStockmoo 评分
1.0
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 3.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -2.5 |
| 平均 | 1.00 |
|
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 30.19% |
| 机构持股比例 | 16.81% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Chapin Davis, Inc. | 30 Jun 2026 | 888,004 |
| Apis Capital Advisors, Llc | 30 Jun 2026 | 804,882 |
| Truist Financial Corp | 30 Jun 2026 | 326,200 |
| Marathon Capital Management | 30 Jun 2026 | 110,000 |
| Sage Mountain Advisors Llc | 30 Jun 2026 | 106,564 |
| Hightower Advisors, Llc | 30 Jun 2026 | 79,469 |
| Northern Trust Corp | 30 Jun 2026 | 69,745 |
| Landscape Capital Management, L.L.C. | 30 Jun 2026 | 55,263 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合